E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/6/2015 in the Prospect News PIPE Daily.

Aurora seals C$3.75 million placement of stock with C$781,250 tranche

Non-brokered deal sells 3.02 million common shares at C$1.25 per share

By Devika Patel

Knoxville, Tenn., March 6 – Aurora Spine Corp. said it raised C$781,250 in the second and final tranche of a C$3.75 million non-brokered private placement of stock. The deal raised C$2.97 million on Feb. 20, when the company said it could raise up to C$4 million in the sale.

The company sold 3,002,000 common shares at C$1.25 apiece. The price per share is a 14.39% discount to the Feb. 19 closing share price of C$1.46. Aurora sold 2,377,000 shares in the initial tranche and 625,000 shares in the second.

Director David Rosenkrantz invested C$200,000 in the first tranche by buying 160,000 shares.

Proceeds will be used for general working capital purposes.

The spinal implant technology company is based in Carlsbad, Calif.

Issuer:Aurora Spine Corp.
Issue:Common stock
Amount:C$3,752,500
Shares:3,002,000
Price:C$1.25
Warrants:No
Agent:Non-brokered
Investor:David Rosenkrantz (for C$200,000)
Settlement dates:Feb. 20 (for C$2,971,250), March 6 (for C$781,250)
Stock symbol:TSX Venture: ASG
Stock price:C$1.46 at close Feb. 19
Market capitalization:C$29.95 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.